Ushijima Tomoki, Shiose Akira
Department of Cardiovascular Surgery, Kyusyu University, Fukuoka, Japan.
Kyobu Geka. 2018 Jul;71(7):513-518.
In the era of implantable ventricular assist device (VAD), the role of extracorporeal VAD is changing. The extracorporeal VAD was ever the mainstream of treatment for severe heart failure. Now, it is mainly applied to patients with severe cardiogenic shock. Recently the centrifugal pump available for cardiopulmonary bypass system has been often used as the extracorporeal VAD because of its simplicity of management. Although the implantable VAD plays the pivotal role for bridge to transplantation since its clinical introduction in 2011, the extracorporeal VAD still has the important role for end-stage heart failure and cardiogenic shock. We have experienced 47 cases of the extracorporeal VAD until now. Here, based on our experience, we describe the "past and present" role of the extracorporeal VAD and mention the future aspect of the extracorporeal VAD.
在可植入式心室辅助装置(VAD)的时代,体外VAD的作用正在发生变化。体外VAD曾经是严重心力衰竭治疗的主流。如今,它主要应用于严重心源性休克患者。最近,由于管理简便,可用于体外循环系统的离心泵常被用作体外VAD。尽管自2011年临床应用以来,可植入式VAD在心脏移植过渡中发挥着关键作用,但体外VAD在终末期心力衰竭和心源性休克中仍具有重要作用。到目前为止,我们已经治疗了47例体外VAD患者。在此,基于我们的经验,我们描述体外VAD的“过去与现在”的作用,并提及体外VAD的未来发展方向。